Introduction
============

The molecular targets of selection favoring brain expansion during human evolution have been sought by identifying dramatic, lineage-specific shifts in evolutionary rate. The increase in DUF1220 domains during human evolution provides one of the most dramatic increases in copy number ([@evv122-B42]; [@evv122-B18]). A single copy of this protein domain is found in *PDE4DIP* in most mammalian genomes. In primates, this ancestral domain has been duplicated many times over, reaching its peak abundance in humans where several hundred DUF1220 domains exist across 20--30 genes in the Nuclear Blastoma Breakpoint Family (NBPF) ([@evv122-B52]; [@evv122-B18]). The majority of these map to 1q21.1, a chromosomal region with complex, and unstable genomic architecture ([@evv122-B36], [@evv122-B37]).

Interspecific DUF1220 counts show a pattern of phylogenetic decay with increasing distance from humans ([@evv122-B42]; [@evv122-B17]; [@evv122-B18]). In humans, DUF1220 dosage has also been linked to head circumference ([@evv122-B18]), and severe neurodevelopmental disorders, including autism spectrum disorder (ASD) and microcephaly ([@evv122-B18]; [@evv122-B15]). The severity of ASD impairments is also correlated with 1q21.1 DUF1220 copy number suggesting a dosage effect ([@evv122-B15]). Taken together, these observations led to the suggestion that the expansion of DUF1220 copy number played a primary role in human brain evolution ([@evv122-B17]; [@evv122-B26]).

Although functional data are limited, they provide some indication of how DUF1220 domain copy number count influences brain development. DUF1220 domains are highly expressed during periods of cortical neurogenesis, suggesting a potential role in prolonging the proliferation of neural progenitors by regulating centriole and microtubule dynamics to control key cell fate switches critical for neurogenesis ([@evv122-B27]). *PDE4DIP*, which contains the ancestral DUF1220 domain, does indeed associate with the spindle poles ([@evv122-B42]) and is homologous to *CDK5RAP2*, a centrosomal protein essential for neural proliferation ([@evv122-B6]; [@evv122-B7]), which coevolved with brain mass across primates ([@evv122-B33]).

Two previous analyses report a significant association between DUF1220 copy number and brain mass, cortical neuron number ([@evv122-B18]), cortical gray and white matter, surface area, and gyrification ([@evv122-B27]). However, several limitations in these analyses restrict confidence in the results. First, DUF1220 copy number was assessed across species using a BLAT/BLAST (BLAST-like alignment tool/Basic Local Alignment Search Tool) analysis with a query sequence from humans, which introduces a bias that could partly explain the observed phylogenetic decay. Second, counts were not restricted to those domains occurring in functional exonic sequence and therefore many DUF1220 domains found in human pseudogenes were included in the analyses. Third, the analyses were limited to a small number of species (4--8 primates), using parametric statistics that may not be suitable for count data, and which do not correct for phylogenetic nonindependence ([@evv122-B20]). This is not a negligible issue, as it can result in the overestimation of statistical significance ([@evv122-B8]). Finally, previous phenotypic associations have been reported for multiple cortical phenotypes all of which are strongly correlated with one another or are nonindependent. Therefore, to date, these studies have not provided evidence for a specific association with neocortex size, neither have they tested the strength of the association with different periods of brain development, which may provide new clues as to the functional relevance of DUF1220 domain copy number.

Here, we use nucleotide Hidden Markov Models (HMMs) (HMMER3; [@evv122-B19]) to more accurately query the DUF1220 domain number of distantly related genomes. After filtering these counts to limit the analysis to exonic sequence, we use phylogenetic comparative methods that correct for nonindependence to test whether DUF1220 copy number is robustly associated with brain size, whether this is due to an association with pre- or postnatal brain development, and whether the association is specific to the neocortex.

Results
=======

We confirm significant interspecific variation in DUF1220 counts across primates ([table 1](#evv122-T1){ref-type="table"}, [fig. 1](#evv122-F1){ref-type="fig"}). Phylogenetic Generalized Least Square (PGLS) regressions ([@evv122-B39]) using square-root, or log~10~-transformed DUF1220 counts support previous reports of an association with brain volume (SQRT: *t*~10~ = 3.165, *P* = 0.005, *R*^2^ = 0.455; log~10~: *t*~10~ = 4.770, *P* \< 0.001, *R*^2^ = 0.655). The same associations are also found after excluding *Homo sapiens* from the analysis (SQRT: *t*~9~ = 3.810, *P* = 0.002, *R*^2^ = 0.569; log~10~: *t*~9~ = 3.952, *P* = 0.002, *R*^2^ = 0.586). However, these data transformations may not be appropriate for count data where models based on Poisson distributions provide more accurate results ([@evv122-B38]). F[ig]{.smallcaps}. 1.--- (*a*) Phylogeny of Ensembl primate genomes showing the number of DUF1220 domains in functional, annotated genes with a CM promoter, and brain mass. (*b*) The relationship between square-root transformed DUF1220 counts and log~10~(brain mass), and (*c*) the relationship between log~10~ transformed DUF1220 counts and log~10~(brain mass). The regression lines are shown with (red) and without (gray) the inclusion of the *H. sapiens* data. In all cases, they are significant. Table 1DUF1220 Count DatanHMMSpecies[@evv122-B36]Whole GenomeFunctional Exonic with CM Promoter*Homo sapiens*272302262*Pan troglodytes*12513832*Gorilla gorilla*999732*Pongo abelii*9210127*Nomascus leucogenys*53596*Papio anubis*---7515*Chlorocebus sabaeus*---4816*Macaca mulatta*357410*Callithrix jacchus*31759*Tarsius syrichta*---472*Microcebus murinus*241*Otolemur garnettii*342

Using a Bayesian approach that corrects for phylogenetic nonindependence and fits a Poisson distribution to the DUF1220 count data (MCMCglmm; [@evv122-B21]), we again find evidence that CM-associated exonic DUF1220 counts are associated with brain mass across primates (*n* = 12, posterior mean = 1.927, 95% confidence interval \[CI\] = 0.800--3.040, *P*~MCMC~ = 0.001). This association is robust to the exclusion of *H. sapiens* (posterior mean = 1.271, 95% CI = 0.490--2.019, *P*~MCMC~ = 0.003), and found when hominoids (*n* = 5, posterior mean = 3.679, 95% CI = 0.966--6.258, *P*~MCMC~ = 0.018) or anthropoids (*n* = 9, posterior mean = 2.019, 95% CI = 0.352--3.684, *P*~MCMC~ = 0.010) are analyzed alone, suggesting a consistent phylogenetic association. When body mass is included as a cofactor in the model, the positive association is restricted to brain mass ([table 2](#evv122-T2){ref-type="table"}*a*, [fig. 1](#evv122-F1){ref-type="fig"}*a*). Table 2MCMCglmm Results of Multivariate ModelsModelPosterior Mean95% CI*P*~MCMC~**(*a*) Brain Mass and Body Mass**    1. log(brain mass)4.1052.163 to 6.0000.001    + log(body mass)−1.986−3.544 to −3.9000.988**(*b*) Prenatal and Postnatal Growth**    1. log(prenatal brain growth)−2.158−4.471 to 0.1060.967    + log(postnatal brain growth)3.3191.470 to 4.9820.002    2. log(postnatal brain growth)2.9101.641 to 4.151\<0.001    + log(postnatal body growth)−1.241−2.442 to −0.0520.977**(*c*) Brain Regions**    1. log(neocortex volume)5.9610.720 to 11.1730.014    + log(RoB volume)−5.817−13.322 to 1.1200.953    2. log(cerebellum volume)3.699−5.857 to 12.6110.186    + log(RoB volume)−2.435−13.869 to 10.1320.681    3. log(neocortex volume)6.076−0.139 to 12.57120.025    + log(cerebellum volume)−0.369−9.5128 to 8.9610.526    + log(RoB volume)−5.494−15.814 to 5.2880.872

Separation of pre- and postnatal development specifically links DUF12220 number to postnatal brain growth. Analyzed separately, the association with prenatal brain growth is weaker (*n* = 11, posterior mean = 1.758, 95% CI =−0.039 to 3.543, *P*~MCMC~ = 0.023) than with postnatal brain growth (posterior mean = 1.839, 95% CI = 0.895--2.808, *P*~MCMC~ = 0.001). If both traits are included in the same model, only the positive association with postnatal brain growth remains ([table 2](#evv122-T2){ref-type="table"}*b*, [fig. 2](#evv122-F2){ref-type="fig"}*b* model 1). Multiple regression analysis also confirms that the association is specific to postnatal brain growth, rather than postnatal body growth ([table 2](#evv122-T2){ref-type="table"}*b* model 2). F[ig]{.smallcaps}. 2.--- (*a*) Posterior means of the association between DUF1220 count and brain mass (red) and body mass (black). (*b*) Posterior means of the association between DUF1220 count and postnatal brain growth (red) and prenatal brain growth (black). (*c*) Posterior means of the association between DUF1220 count and neocortex volume (red), cerebellum volume (solid black), and rest-of-brain volume (dashed black).

Finally, we not only examined the hypothesized relationship with neocortex volume (e.g., [@evv122-B27]; [@evv122-B27]), but also considered cerebellum volume, as this region coevolves with the neocortex ([@evv122-B3]), has expanded in apes ([@evv122-B4]), and shows high levels of NBPF expression ([@evv122-B42]). When the rest-of-the-brain (RoB) is included as a cofactor, to account for variation in overall brain size, a positive association is found for neocortex volume but not cerebellum volume ([table 2](#evv122-T2){ref-type="table"}*c* models 1-3, [fig. 2](#evv122-F2){ref-type="fig"}*c*).

Discussion
==========

Our phylogenetic analyses substantiate the hypothesis that the increase in DUF1220 number coevolves with brain mass ([@evv122-B18]; [@evv122-B27]), and may contribute to the proximate basis of primate brain evolution. We extend the results of previous studies by demonstrating specific associations with neocortex volume, and postnatal brain growth rather than prenatal brain growth. Together these results imply a role for DUF1220 in evolutionary changes in the maturation and postnatal development of the neocortex. Previous hypotheses concerning the phenotypic relevance of DUF1220 domain number have focused on their possible contribution to neurogenesis ([@evv122-B17]; [@evv122-B27]; [@evv122-B27]). This is supported by homology to genes with known functions in cell cycle dynamics ([@evv122-B42]; [@evv122-B48]), relevant spatial and temporal expression patterns ([@evv122-B27]), and an effect on the proliferation of neuroblastoma cell cultures ([@evv122-B50]). However, a direct effect of variation in DUF1220 domain number on neural proliferation has not been demonstrated ([@evv122-B28]).

If DUF1220 domains do regulate neurogenesis, we would expect them to coevolve with prenatal brain growth, as cortical neurogenesis is restricted to prenatal development ([@evv122-B5]). Our results instead suggest a robust and specific relationship with postnatal brain development. Existing data on DUF1220 domain function suggest two potential roles that may explain this association: 1) a contribution to axonogenesis through initiating and stabilizing microtubule growth in dendrites; and 2) a potential role in apoptosis during brain maturation. Both hypotheses are consistent with the reported association between variation in DUF1220 dosage and ASD ([@evv122-B15]). Indeed, an emphasis on postnatal brain growth is potentially more relevant for ASD, which develops postnatally, accompanied by a period of accelerated brain growth in early postnatal development ([@evv122-B12]).

Microtubule assembly is essential for dendritic growth and axonogenesis ([@evv122-B11]). *PDE4DIP*, which contains the ancestral DUF1220 domain, has known functions in microtubule nucleation, growth, and cell migration ([@evv122-B44]). There is also evidence that NBPF1 interacts with a key regulator of Wnt signaling ([@evv122-B51]) that has important roles in neuronal differentiation, dendritic growth, and plasticity ([@evv122-B23]). Consistent with this function, DUF1220 domains are highly expressed in the cell bodies and dendrites of adult neurons ([@evv122-B42]). A role for DUF1220 domains in synaptogenesis could potentially explain the association with ASD severity ([@evv122-B15]). ASD is associated with abnormalities in cortical minicolumns ([@evv122-B9]) and cortical white matter ([@evv122-B22]; [@evv122-B12]), both of which suggest a disruption of normal neuronal maturation ([@evv122-B13]; [@evv122-B32]).

Alternatively, NBPF genes are also known to interact with NF-κB ([@evv122-B53]), a transcription factor implicated in tumor progression, with a range of roles including apoptosis and inflammation ([@evv122-B24]; [@evv122-B40]). Postnatal apoptosis has a significant influence on brain growth ([@evv122-B29]; [@evv122-B41]; [@evv122-B30]), including regulating neuronal density ([@evv122-B45]), and apoptotic genes may have been targeted by selection in relation to primate brain expansion ([@evv122-B49]). Disruption of apoptosis causes microcephaly ([@evv122-B43]), potentially explaining the association between DUF1220 dosage and head circumference ([@evv122-B18]). The association of NF-κB with inflammatory diseases ([@evv122-B47]) is also intriguing, given the growing evidence that the inflammatory response is linked to the risk and severity of ASD ([@evv122-B31]; [@evv122-B16]).

If DUF1220 domain number does contribute to the evolution of postnatal brain growth, this contrasts with results of previously studied candidate genes with known roles in neurogenesis that coevolve with prenatal brain growth ([@evv122-B33]). This suggests a two-component model of brain evolution where selection targets one set of genes to bring about an increase in neuron number (e.g., [@evv122-B33]; [@evv122-B34], [@evv122-B35]), and an independent set of genes to optimize neurite growth and connectivity (e.g., [@evv122-B10]). NBPF genes may fall into the latter category. This two-component model is consistent with comparative analyses that indicate pre- and postnatal brain developments evolve independently, and must therefore be relatively free of reciprocal pleiotropic effects ([@evv122-B2]).

Finally, these results add further evidence that many of the genetic changes that contribute to human evolution will be based on the continuation or exaggeration of conserved gene-phenotype associations that contribute to primate brain evolution more broadly ([@evv122-B33]; [@evv122-B46]). Understanding the commonalities between human and nonhuman primate brain evolution is therefore essential to understand the genetic differences that contribute the derived aspects of human evolution.

Materials and Methods
=====================

Counting DUF1220 Domains
------------------------

HMMER3.1b ([@evv122-B19]) was used to build an HMM from the DUF1220 (PF06758) seed alignment stored in the PFAM database (Finn et al. 2014). The longest isoforms for all proteomes of 12 primate genomes from Ensembl v.78 ([@evv122-B14]) ([fig. 1](#evv122-F1){ref-type="fig"}*a*) were searched using the protein DUF1220 HMM (hmmsearch, *E* value \< 1e-10) ([supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv122/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv122/-/DC1) online). We extracted the corresponding cDNA regions to build a DUF1220 nucleotide profile HMM (nHMM) using a MAFFT sequence alignment, allowing for more sensitive analysis across a broad phylogenetic range. The DUF1220 nHMM was used to search the complete genomic DNA for all 12 species. These counts were filtered to remove any DUF1220 domains not located in annotated exonic sequence, or located in known pseudogenes.

We next filtered our counts to limit them to exonic sequence in close proximity to the NBPF-specific Conserved-Mammal (CM) promoter ([@evv122-B36]). To do so, we built a nucleotide HMM for the CM promoter based on a MAFFT ([@evv122-B25]) alignment of the 900-bp CM region upstream of human genes *NBPF4*, *NBPF6*, and *NBPF7*. Using this CM promoter nHMM, we searched 1,000-bp up- and downstream of genes containing DUF1220 domains for significant CM promoter hits (nhmmer, *E* value \< 1e-10). This provided final counts for DUF1220 domains within exonic regions and associated with the CM promoter ([table 1](#evv122-T1){ref-type="table"}). These counts were used in subsequent phylogenetic analyses. In the [supplementary information](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv122/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv122/-/DC1) online, we compare our counts with previous estimates and discuss possible sources of error. All scripts and data used in the analysis are freely available from: <https://github.com/qfma/duf1220>

Phylogenetic Gene-Phenotype Analysis
------------------------------------

PGLS regressions were performed using log-transformed phenotypic data and log- or square root-transformed DUF1220 count data in BayesTraits ([@evv122-B39]). Phylogenetic multivariate generalized mixed models were implemented using a Bayesian approach in MCMCglmm ([@evv122-B21]), to test for phylogenetically corrected associations between DUF1220 counts and log-transformed phenotypic data ([supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv122/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv122/-/DC1) online). All analyses were performed using a Poisson distribution, as recommended for count data ([@evv122-B38]), with uninformative, parameter expanded priors for the random effect (G: V = 1,n ν = 1, alpha.ν = 0, alpha.V = 1,000; R: V = 1, ν = 0.002) and default priors for the fixed effects. Phylogenetic relationships were taken from the 10k Trees project ([@evv122-B1]). We report the posterior mean of the cofactor included in each model and its 95% CIs, and the probability that the parameter value is greater than 0 (*P*~MCMC~) as we specifically hypothesize a positive association ([@evv122-B18]). Alternative data treatments lead to similar conclusions ([supplementary information](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv122/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv122/-/DC1) online).
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